Separation and Identification of APO-B-Containing Lipoprotein Particles in Normolipidemic Subjects and Patients with Hyperlipoproteinemias View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1987

AUTHORS

Petar Alaupovic , Marcelo Tavella , James Fesmire

ABSTRACT

The operationally-defined plasma lipoproteins have provided the theoretical basis for most studies and current views on the mechanism of lipid transport [1,2]. The popularity of these classification systems has been enhanced by clinical studies which have related certain derangements of lipid transport to particular density classes or electrophoretic patterns [2,3]. However, the discovery of a number of apolipoproteins [1,4] and the detection of marked protein heterogeneity of lipoprotein density classes and electrophoretic bands [4,5] have become incompatible with the view that operationally-defined lipoproteins represent the fundamental chemical and metabolic entities of lipid transport system. Results from laboratories have shown that major density classes consist of several distinct lipoprotein families or particles rather than single lipid-protein complexes [4-9]. Based on these and similar findings showing that lipoprotein density classes consist of distinct lipoprotein particles of similar hydrated densities but different apolipoprotein composition, we have proposed that apo-lipoproteins be used as specific markers for the identification of lipoprotein particles and as a new means for the classification of plasma lipoproteins [10,11]. According to this proposal, lipoprotein families or particles which contain a single apolipoprotein are called simple lipoproteins and those which contain two or more apolipoproteins are referred to as complexlipoproteins [11]. The nomenclature of lipoprotein particles is based on the ABC nomenclature of apolipoproteins [10] in that lipoprotein particles are named after their constitutive apolipoproteins. For example, lipoprotein particles which only contain ApoB as their protein moiety are called lipoprotein B (LP-B), while lipoprotein particles which contain apolipoproteins B, C and E are named lipoprotein B:C:E (LP-B:C:E). More... »

PAGES

7-14

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4684-1268-0_2

DOI

http://dx.doi.org/10.1007/978-1-4684-1268-0_2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1049409530

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/3591557


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1101", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Biochemistry and Metabolomics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apolipoproteins B", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hyperlipoproteinemias", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoelectrophoresis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lipoproteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Precipitin Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Binding", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reference Values", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Lipoprotein and Atherosclerosis Research Program, Oklahoma Medical Research Foundation, 73104, Oklahoma City, Oklahoma, USA", 
          "id": "http://www.grid.ac/institutes/grid.274264.1", 
          "name": [
            "Lipoprotein and Atherosclerosis Research Program, Oklahoma Medical Research Foundation, 73104, Oklahoma City, Oklahoma, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alaupovic", 
        "givenName": "Petar", 
        "id": "sg:person.077536524.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.077536524.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Lipoprotein and Atherosclerosis Research Program, Oklahoma Medical Research Foundation, 73104, Oklahoma City, Oklahoma, USA", 
          "id": "http://www.grid.ac/institutes/grid.274264.1", 
          "name": [
            "Lipoprotein and Atherosclerosis Research Program, Oklahoma Medical Research Foundation, 73104, Oklahoma City, Oklahoma, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tavella", 
        "givenName": "Marcelo", 
        "id": "sg:person.01145621773.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145621773.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Lipoprotein and Atherosclerosis Research Program, Oklahoma Medical Research Foundation, 73104, Oklahoma City, Oklahoma, USA", 
          "id": "http://www.grid.ac/institutes/grid.274264.1", 
          "name": [
            "Lipoprotein and Atherosclerosis Research Program, Oklahoma Medical Research Foundation, 73104, Oklahoma City, Oklahoma, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fesmire", 
        "givenName": "James", 
        "id": "sg:person.0707005107.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707005107.03"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1987", 
    "datePublishedReg": "1987-01-01", 
    "description": "The operationally-defined plasma lipoproteins have provided the theoretical basis for most studies and current views on the mechanism of lipid transport [1,2]. The popularity of these classification systems has been enhanced by clinical studies which have related certain derangements of lipid transport to particular density classes or electrophoretic patterns [2,3]. However, the discovery of a number of apolipoproteins [1,4] and the detection of marked protein heterogeneity of lipoprotein density classes and electrophoretic bands [4,5] have become incompatible with the view that operationally-defined lipoproteins represent the fundamental chemical and metabolic entities of lipid transport system. Results from laboratories have shown that major density classes consist of several distinct lipoprotein families or particles rather than single lipid-protein complexes [4-9]. Based on these and similar findings showing that lipoprotein density classes consist of distinct lipoprotein particles of similar hydrated densities but different apolipoprotein composition, we have proposed that apo-lipoproteins be used as specific markers for the identification of lipoprotein particles and as a new means for the classification of plasma lipoproteins [10,11]. According to this proposal, lipoprotein families or particles which contain a single apolipoprotein are called simple lipoproteins and those which contain two or more apolipoproteins are referred to as complexlipoproteins [11]. The nomenclature of lipoprotein particles is based on the ABC nomenclature of apolipoproteins [10] in that lipoprotein particles are named after their constitutive apolipoproteins. For example, lipoprotein particles which only contain ApoB as their protein moiety are called lipoprotein B (LP-B), while lipoprotein particles which contain apolipoproteins B, C and E are named lipoprotein B:C:E (LP-B:C:E).", 
    "editor": [
      {
        "familyName": "Malmendier", 
        "givenName": "C. L.", 
        "type": "Person"
      }, 
      {
        "familyName": "Alaupovic", 
        "givenName": "P.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4684-1268-0_2", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4684-1270-3", 
        "978-1-4684-1268-0"
      ], 
      "name": "Lipoproteins and Atherosclerosis", 
      "type": "Book"
    }, 
    "keywords": [
      "lipid-protein complexes", 
      "number of apolipoprotein", 
      "distinct lipoprotein families", 
      "particles", 
      "protein heterogeneity", 
      "moiety", 
      "major density classes", 
      "lipoprotein density classes", 
      "protein moiety", 
      "complexes", 
      "separation", 
      "lipoprotein particles", 
      "plasma lipoproteins", 
      "hydrated density", 
      "electrophoretic bands", 
      "composition", 
      "new means", 
      "transport", 
      "lipoprotein families", 
      "band", 
      "lipid transport", 
      "clinical studies", 
      "apolipoprotein B", 
      "lipid transport system", 
      "normolipidemic subjects", 
      "distinct lipoprotein particles", 
      "apolipoprotein composition", 
      "detection", 
      "density", 
      "lipoprotein B", 
      "similar findings", 
      "lipoproteins", 
      "certain derangements", 
      "apolipoproteins", 
      "more apolipoproteins", 
      "specific markers", 
      "class", 
      "discovery", 
      "metabolic entities", 
      "apo", 
      "system", 
      "most studies", 
      "mechanism", 
      "classification system", 
      "identification", 
      "means", 
      "density classes", 
      "patients", 
      "hyperlipoproteinemia", 
      "derangement", 
      "study", 
      "electrophoretic patterns", 
      "basis", 
      "laboratory", 
      "single apolipoprotein", 
      "theoretical basis", 
      "current view", 
      "markers", 
      "subjects", 
      "example", 
      "results", 
      "findings", 
      "family", 
      "entities", 
      "nomenclature", 
      "transport system", 
      "heterogeneity", 
      "view", 
      "patterns", 
      "number", 
      "classification", 
      "popularity", 
      "proposal", 
      "particular density classes", 
      "single lipid-protein complexes", 
      "similar hydrated densities", 
      "different apolipoprotein composition", 
      "simple lipoproteins", 
      "complexlipoproteins", 
      "ABC nomenclature", 
      "constitutive apolipoproteins", 
      "Identification of APO"
    ], 
    "name": "Separation and Identification of APO-B-Containing Lipoprotein Particles in Normolipidemic Subjects and Patients with Hyperlipoproteinemias", 
    "pagination": "7-14", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1049409530"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4684-1268-0_2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "3591557"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4684-1268-0_2", 
      "https://app.dimensions.ai/details/publication/pub.1049409530"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2021-11-01T18:59", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/chapter/chapter_411.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-4684-1268-0_2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-1268-0_2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-1268-0_2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-1268-0_2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-1268-0_2'


 

This table displays all metadata directly associated to this object as RDF triples.

212 TRIPLES      22 PREDICATES      120 URIs      113 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4684-1268-0_2 schema:about N3b4a26a238b14a6d97b2ba27ab62c203
2 N4e7fdf2f3ff84390898721ae6de49828
3 N4ffd43a0d4814ce090795d8b4c35d04b
4 N59f6a64c5f604e74ba19fe85a06b8606
5 N8c48e33259d24c93b2b5b9c540c1f36a
6 Naa47efe097a843a4a3310de536d496cb
7 Nbe0a26bf50334503afce9289ad9a1bdb
8 Nced4976c03574876b14484ed687a3e46
9 Nd1485c549f5e4283961d1d7ca0011089
10 Nd84592ca57604180b428d986c306c445
11 Nf889222b749141cebf67419835ca8541
12 Nf8f0358e78ef4000b059da98ee0d3cc7
13 anzsrc-for:11
14 anzsrc-for:1101
15 schema:author Nf1ae355fc9d94e189a4a9d792cab9f40
16 schema:datePublished 1987
17 schema:datePublishedReg 1987-01-01
18 schema:description The operationally-defined plasma lipoproteins have provided the theoretical basis for most studies and current views on the mechanism of lipid transport [1,2]. The popularity of these classification systems has been enhanced by clinical studies which have related certain derangements of lipid transport to particular density classes or electrophoretic patterns [2,3]. However, the discovery of a number of apolipoproteins [1,4] and the detection of marked protein heterogeneity of lipoprotein density classes and electrophoretic bands [4,5] have become incompatible with the view that operationally-defined lipoproteins represent the fundamental chemical and metabolic entities of lipid transport system. Results from laboratories have shown that major density classes consist of several distinct lipoprotein families or particles rather than single lipid-protein complexes [4-9]. Based on these and similar findings showing that lipoprotein density classes consist of distinct lipoprotein particles of similar hydrated densities but different apolipoprotein composition, we have proposed that apo-lipoproteins be used as specific markers for the identification of lipoprotein particles and as a new means for the classification of plasma lipoproteins [10,11]. According to this proposal, lipoprotein families or particles which contain a single apolipoprotein are called simple lipoproteins and those which contain two or more apolipoproteins are referred to as complexlipoproteins [11]. The nomenclature of lipoprotein particles is based on the ABC nomenclature of apolipoproteins [10] in that lipoprotein particles are named after their constitutive apolipoproteins. For example, lipoprotein particles which only contain ApoB as their protein moiety are called lipoprotein B (LP-B), while lipoprotein particles which contain apolipoproteins B, C and E are named lipoprotein B:C:E (LP-B:C:E).
19 schema:editor N087042df38f246e7af28273645bf7deb
20 schema:genre chapter
21 schema:isAccessibleForFree false
22 schema:isPartOf Ne1300968e21e4e39a1960eeef6654804
23 schema:keywords ABC nomenclature
24 Identification of APO
25 apo
26 apolipoprotein B
27 apolipoprotein composition
28 apolipoproteins
29 band
30 basis
31 certain derangements
32 class
33 classification
34 classification system
35 clinical studies
36 complexes
37 complexlipoproteins
38 composition
39 constitutive apolipoproteins
40 current view
41 density
42 density classes
43 derangement
44 detection
45 different apolipoprotein composition
46 discovery
47 distinct lipoprotein families
48 distinct lipoprotein particles
49 electrophoretic bands
50 electrophoretic patterns
51 entities
52 example
53 family
54 findings
55 heterogeneity
56 hydrated density
57 hyperlipoproteinemia
58 identification
59 laboratory
60 lipid transport
61 lipid transport system
62 lipid-protein complexes
63 lipoprotein B
64 lipoprotein density classes
65 lipoprotein families
66 lipoprotein particles
67 lipoproteins
68 major density classes
69 markers
70 means
71 mechanism
72 metabolic entities
73 moiety
74 more apolipoproteins
75 most studies
76 new means
77 nomenclature
78 normolipidemic subjects
79 number
80 number of apolipoprotein
81 particles
82 particular density classes
83 patients
84 patterns
85 plasma lipoproteins
86 popularity
87 proposal
88 protein heterogeneity
89 protein moiety
90 results
91 separation
92 similar findings
93 similar hydrated densities
94 simple lipoproteins
95 single apolipoprotein
96 single lipid-protein complexes
97 specific markers
98 study
99 subjects
100 system
101 theoretical basis
102 transport
103 transport system
104 view
105 schema:name Separation and Identification of APO-B-Containing Lipoprotein Particles in Normolipidemic Subjects and Patients with Hyperlipoproteinemias
106 schema:pagination 7-14
107 schema:productId N263eed2072cb49a8b5b8d4a2c76c8995
108 N6c58bcfbdcea4d75aa4dc83e777d372c
109 Nb87766da291e4ecab032f4263ef9394d
110 schema:publisher N0b6cf6b4acfa4be8a9b40d594a9dc307
111 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049409530
112 https://doi.org/10.1007/978-1-4684-1268-0_2
113 schema:sdDatePublished 2021-11-01T18:59
114 schema:sdLicense https://scigraph.springernature.com/explorer/license/
115 schema:sdPublisher N0c9a64ef200541b4b43b1fdbba201f98
116 schema:url https://doi.org/10.1007/978-1-4684-1268-0_2
117 sgo:license sg:explorer/license/
118 sgo:sdDataset chapters
119 rdf:type schema:Chapter
120 N087042df38f246e7af28273645bf7deb rdf:first Nce31534cf6b2429cb06342c44224ec37
121 rdf:rest Ndc18b400d45e4feebbb5cf5e29ff8a6a
122 N0b6cf6b4acfa4be8a9b40d594a9dc307 schema:name Springer Nature
123 rdf:type schema:Organisation
124 N0c9a64ef200541b4b43b1fdbba201f98 schema:name Springer Nature - SN SciGraph project
125 rdf:type schema:Organization
126 N1e702d9133a94b2e83d11b42bcb0e11c rdf:first sg:person.0707005107.03
127 rdf:rest rdf:nil
128 N263eed2072cb49a8b5b8d4a2c76c8995 schema:name pubmed_id
129 schema:value 3591557
130 rdf:type schema:PropertyValue
131 N3b4a26a238b14a6d97b2ba27ab62c203 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Adult
133 rdf:type schema:DefinedTerm
134 N4e7fdf2f3ff84390898721ae6de49828 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Apolipoproteins B
136 rdf:type schema:DefinedTerm
137 N4ffd43a0d4814ce090795d8b4c35d04b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Precipitin Tests
139 rdf:type schema:DefinedTerm
140 N50a2a7501a73422f84f3bb0f579e02f6 schema:familyName Alaupovic
141 schema:givenName P.
142 rdf:type schema:Person
143 N59f6a64c5f604e74ba19fe85a06b8606 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Hyperlipoproteinemias
145 rdf:type schema:DefinedTerm
146 N6c58bcfbdcea4d75aa4dc83e777d372c schema:name dimensions_id
147 schema:value pub.1049409530
148 rdf:type schema:PropertyValue
149 N8c48e33259d24c93b2b5b9c540c1f36a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Humans
151 rdf:type schema:DefinedTerm
152 Naa47efe097a843a4a3310de536d496cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Middle Aged
154 rdf:type schema:DefinedTerm
155 Nb87766da291e4ecab032f4263ef9394d schema:name doi
156 schema:value 10.1007/978-1-4684-1268-0_2
157 rdf:type schema:PropertyValue
158 Nbe0a26bf50334503afce9289ad9a1bdb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Protein Binding
160 rdf:type schema:DefinedTerm
161 Nce31534cf6b2429cb06342c44224ec37 schema:familyName Malmendier
162 schema:givenName C. L.
163 rdf:type schema:Person
164 Nced4976c03574876b14484ed687a3e46 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Male
166 rdf:type schema:DefinedTerm
167 Nd1485c549f5e4283961d1d7ca0011089 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Lipoproteins
169 rdf:type schema:DefinedTerm
170 Nd5db9b75ca22453f9d989cd3d0512a2c rdf:first sg:person.01145621773.36
171 rdf:rest N1e702d9133a94b2e83d11b42bcb0e11c
172 Nd84592ca57604180b428d986c306c445 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Reference Values
174 rdf:type schema:DefinedTerm
175 Ndc18b400d45e4feebbb5cf5e29ff8a6a rdf:first N50a2a7501a73422f84f3bb0f579e02f6
176 rdf:rest rdf:nil
177 Ne1300968e21e4e39a1960eeef6654804 schema:isbn 978-1-4684-1268-0
178 978-1-4684-1270-3
179 schema:name Lipoproteins and Atherosclerosis
180 rdf:type schema:Book
181 Nf1ae355fc9d94e189a4a9d792cab9f40 rdf:first sg:person.077536524.07
182 rdf:rest Nd5db9b75ca22453f9d989cd3d0512a2c
183 Nf889222b749141cebf67419835ca8541 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Immunoelectrophoresis
185 rdf:type schema:DefinedTerm
186 Nf8f0358e78ef4000b059da98ee0d3cc7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Female
188 rdf:type schema:DefinedTerm
189 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
190 schema:name Medical and Health Sciences
191 rdf:type schema:DefinedTerm
192 anzsrc-for:1101 schema:inDefinedTermSet anzsrc-for:
193 schema:name Medical Biochemistry and Metabolomics
194 rdf:type schema:DefinedTerm
195 sg:person.01145621773.36 schema:affiliation grid-institutes:grid.274264.1
196 schema:familyName Tavella
197 schema:givenName Marcelo
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145621773.36
199 rdf:type schema:Person
200 sg:person.0707005107.03 schema:affiliation grid-institutes:grid.274264.1
201 schema:familyName Fesmire
202 schema:givenName James
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707005107.03
204 rdf:type schema:Person
205 sg:person.077536524.07 schema:affiliation grid-institutes:grid.274264.1
206 schema:familyName Alaupovic
207 schema:givenName Petar
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.077536524.07
209 rdf:type schema:Person
210 grid-institutes:grid.274264.1 schema:alternateName Lipoprotein and Atherosclerosis Research Program, Oklahoma Medical Research Foundation, 73104, Oklahoma City, Oklahoma, USA
211 schema:name Lipoprotein and Atherosclerosis Research Program, Oklahoma Medical Research Foundation, 73104, Oklahoma City, Oklahoma, USA
212 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...